Dual-chamber pen injector · Cartridge coordination · OEM project pathway

Dual chamber pen injector systems

A dual-chamber pen injector keeps a dry component and diluent separated before preparation. REVADUO coordinates the reusable pen platform, cartridge interface, needle options and secondary packaging so pharmaceutical teams can evaluate one connected delivery-system pathway.

dual chamber pen injectordual chamber injection pendual chamber cartridge penpowder-liquid pen
Screen the system, not one loose component

Cartridge dimensions, bypass behavior, stopper interfaces, dose requirements and target-market documents must be reviewed together.

Reusable dual-chamber injection pen platform

What buyers evaluate first

This platform page covers the category-level questions behind searches for dual-chamber injection pens, reconstitution pens and cartridge-based delivery systems.

01 · Separation

Powder and diluent remain apart

The system architecture is intended for projects that require components to stay separated until preparation. The formulation and filling process remain the pharmaceutical sponsor’s responsibility.

02 · Interface

Pen and cartridge are matched

Cartridge geometry, stopper travel, bypass location and device engagement influence whether the selected components can be evaluated as a system.

03 · Delivery

Dose requirements guide configuration

Fill volume, dose step, maximum single delivery and expected use cycle are screened before samples or commercial terms are confirmed.

Platform evaluation path

Buyer questionInformation to provideProject output
Will the system fit our formulation concept?Fill ratio, target reconstituted volume, viscosity and dose rangeInitial device-and-cartridge screening
Can we use a reusable pen?Injection frequency, cartridge-change expectations and user groupReusable-platform review and evidence gap list
Can it be customized?Color, logo, packaging, market and annual volumeOEM route, sample scope and quotation inputs

Important project boundary

This webpage does not establish drug compatibility, clinical suitability, dose accuracy for an untested configuration or market authorization. Those conclusions require configuration-specific evidence and sponsor review.

  • Define the cartridge before confirming the pen.
  • Confirm target market before defining the document set.
  • Use samples to review physical configuration before ordering.

Define the platform around your project

Share fill volume, dose range, cartridge status, target market and expected quantity.

Request a project review →
WhatsApp+86 131 9303 2415